ST Pharm Co.,Ltd. (KOSDAQ:237690)
77,300
-700 (-0.90%)
Jun 19, 2025, 3:30 PM KST
ST Pharm Revenue
ST Pharm had revenue of 52.42B KRW in the quarter ending March 31, 2025, with 1.35% growth. This brings the company's revenue in the last twelve months to 274.45B, down -4.06% year-over-year. In the year 2024, ST Pharm had annual revenue of 273.75B, down -3.94%.
Revenue (ttm)
274.45B
Revenue Growth
-4.06%
P/S Ratio
5.73
Revenue / Employee
419.01M
Employees
655
Market Cap
1,571.93B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 273.75B | -11.24B | -3.94% |
Dec 31, 2023 | 284.99B | 35.67B | 14.31% |
Dec 31, 2022 | 249.32B | 83.68B | 50.52% |
Dec 31, 2021 | 165.64B | 41.53B | 33.47% |
Dec 31, 2020 | 124.11B | 30.85B | 33.08% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,898.69B |
Celltrion | 3,662.23B |
ALTEOGEN | 151.65B |
Yuhan | 2,114.76B |
SK Biopharmaceuticals | 578.00B |
HLB Co., Ltd. | 74.64B |
PharmaResearch | 392.31B |
Peptron | 4.30B |